Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Corcept Therapeutics
Sparrow Pharmaceuticals
National Institutes of Health Clinical Center (CC)
University of Texas Southwestern Medical Center
Johns Hopkins University
Mayo Clinic
RECORDATI GROUP
Sparrow Pharmaceuticals
Mayo Clinic
Corcept Therapeutics
Mayo Clinic
Corcept Therapeutics
Crinetics Pharmaceuticals Inc.
Instituto Nacional de Salud, Colombia
University of Palermo
University of Zurich
Helsinki University Central Hospital
Istituto Auxologico Italiano
Corcept Therapeutics
Zhongnan Hospital
Istituto Auxologico Italiano
Heights
Istanbul Nisantasi University
Uppsala University
Shanghai Jiao Tong University School of Medicine
Region Skane
Marmara University
Novartis
Seoul National University Hospital
Corcept Therapeutics
HRA Pharma
Samsun Liv Hospital
Fondazione Poliambulanza Istituto Ospedaliero
University Hospital, Toulouse
Cedars-Sinai Medical Center
Haukeland University Hospital
Novartis
Corcept Therapeutics
Charles University, Czech Republic
Corcept Therapeutics
Corcept Therapeutics
Corcept Therapeutics